Highlights

  • Visionflex reported annualised Recurring Revenue of about AUD 1.47 million in September, down from AUD 1.95 million in June.
  • Visionflex attributed the reduction in annualised recurring revenue to a tighter definition and the loss of some renewals.
  • The company recorded roughly AUD 900,000 in unaudited first-quarter revenue, an increase of 3% on the comparable period.
  • Visionflex reduced operating and administrative payments by 12% and recorded a net operating cash outflow of about AUD 900,000.

A tighter definition and some missed renewals left Visionflex Group (ASX:VFX) with about AUD 1.47 million in annualised recurring revenue in September, down from AUD 1.95 million at the end of June. The virtual care technology company is relying on undrawn Debt facilities and an expected tax refund to fund operations.

What Visionflex sells

Visionflex describes itself as a clinical diagnostic virtual care technology company. It supplies an integrated hardware and software platform, including carts, mobile kits, examination cameras and ultrasounds, mostly on subscription. Clinicians use it to examine patients remotely. Customers include aged care operators, Aboriginal community controlled health services, the Royal Flying Doctor Service SA/NT and workplace emergency response teams in the resources sector. It also has a US channel partner, ePlus Technology.

The Business is commercial rather than developmental. According to its Appendix 4E, FY2026 revenue was about AUD 4.18 million, down 10%. The net loss narrowed to about AUD 55,000, from about AUD 3.09 million a year earlier. The auditor's report included a material uncertainty paragraph relating to going concern.

The September quarter

Customer receipts were about AUD 0.9 million, down 11%. The share of recurring revenue dropped to about 40%, from 49% a year earlier.

Visionflex said the ARR decline reflected a revised definition that excludes expired subscriptions without a confirmed renewal, together with aged care facilities that did not move to paid subscriptions. It also said Western NSW Local Health District had not renewed a legacy support contract, removing about AUD 90,000 of ARR, although discussions on upgraded equipment were continuing. That is separate from a roughly AUD 0.8 million hardware Supply contract with NSW Health, announced in June, for 127 examination cameras and 162 camera glass kits under a statewide remote patient monitoring programme.

Funding

Cash at 30 September was about AUD 0.66 million. The company reported up to AUD 1.15 million of undrawn facilities, mostly a AUD 0.95 million convertible note Facility from Adcock Private Equity available until August 2027, plus up to AUD 0.2 million under an R&D funding facility. It expects an R&D tax incentive refund of about AUD 0.58 million in the December quarter and plans to use it to repay AUD 0.4 million drawn under that R&D facility plus interest. The Quarterly Report itself does not state a funding runway estimate.

Risks and sector context

Virtual care Demand in Australia has shifted since the pandemic, and health service budgets and grant timing often decide procurement. Further dilution through convertible notes or equity is possible.

Share Trading on 16 November

Volume was only 419 shares, so the quoted change rests on a negligible trade and is not a meaningful signal.

What to watch

The company has said it expects to complete a Royal Flying Doctor Service SA/NT network expansion to eight more locations in November 2026, with about AUD 0.2 million of revenue on delivery. Other priorities include converting quoted enterprise opportunities and moving hardware customers onto subscriptions. A notice of Annual General Meeting was released on 19 October, and the December quarter report is due by late January 2027.